Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug

NCT02378194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Renal Failure

Interventions

DRUG: Placebo
DRUG: HD-003 (800mg/day)
DRUG: HD-003 (1600mg/day)

Sponsor

Hyundai Pharmaceutical Co., LTD.